Performance of chronic schizophrenic patients on cognitive neuropsychological measures sensitive to dementia

Philip D Harvey, Janel Lombardi, Martin Leibman, Leonard White, Michael Parrella, Peter Powchik, Richard C. Mohs, Michael Davidson

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Although many chronic schizophrenic patients manifest substantial global cognitive impairment, it is not clear as to whether this impairment should be characterized as dementia. Since many degenerative dementias have a characteristic signature of cognitive impairment and a specific pattern of cognitive decline, examination of schizophrenic patients on these measures can provide information about the qualitative similarity of their cognitive impairment to these other conditions. Three hundred and two chronically hospitalized schizophrenic patients ranging in age from 26 to 98 were examined with the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) neuropsychological battery, as well as a more global measure of cognitive impairment, the Mini-Mental State Examination (MMSE). This assessment was repeated twice, with a 1-year follow-up interval. The CERAD battery measures the prototypical cognitive deficits of Alzheimer's disease, including word list learning and delayed recall, naming and praxis. In contrast to Alzheimer's disease, all aspects of cognitive impairment were linearly associated with MMSE scores and there were no qualitatively different patterns of deficits associated with MMSE scores in different ranges of severity. There was no change in performance on any measure across the follow-up period, regardless of the MMSE scores of the patients at baseline. These data suggest that the specific patterns of deficit in chronic schizophrenic patients with severe cognitive deficits differ from Alzheimer's disease in both course and profile of impairment.

Original languageEnglish
Pages (from-to)621-627
Number of pages7
JournalInternational Journal of Geriatric Psychiatry
Volume11
Issue number7
DOIs
StatePublished - Jul 1 1996
Externally publishedYes

Fingerprint

Dementia
Alzheimer Disease
Registries
Cognitive Dysfunction
Learning

Keywords

  • Cognitive impairment
  • Dementia
  • Institutionalization
  • Schizophrenia

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Performance of chronic schizophrenic patients on cognitive neuropsychological measures sensitive to dementia. / Harvey, Philip D; Lombardi, Janel; Leibman, Martin; White, Leonard; Parrella, Michael; Powchik, Peter; Mohs, Richard C.; Davidson, Michael.

In: International Journal of Geriatric Psychiatry, Vol. 11, No. 7, 01.07.1996, p. 621-627.

Research output: Contribution to journalArticle

Harvey, Philip D ; Lombardi, Janel ; Leibman, Martin ; White, Leonard ; Parrella, Michael ; Powchik, Peter ; Mohs, Richard C. ; Davidson, Michael. / Performance of chronic schizophrenic patients on cognitive neuropsychological measures sensitive to dementia. In: International Journal of Geriatric Psychiatry. 1996 ; Vol. 11, No. 7. pp. 621-627.
@article{c6f70a14e5324b26badd6dd3fdcfd8ce,
title = "Performance of chronic schizophrenic patients on cognitive neuropsychological measures sensitive to dementia",
abstract = "Although many chronic schizophrenic patients manifest substantial global cognitive impairment, it is not clear as to whether this impairment should be characterized as dementia. Since many degenerative dementias have a characteristic signature of cognitive impairment and a specific pattern of cognitive decline, examination of schizophrenic patients on these measures can provide information about the qualitative similarity of their cognitive impairment to these other conditions. Three hundred and two chronically hospitalized schizophrenic patients ranging in age from 26 to 98 were examined with the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) neuropsychological battery, as well as a more global measure of cognitive impairment, the Mini-Mental State Examination (MMSE). This assessment was repeated twice, with a 1-year follow-up interval. The CERAD battery measures the prototypical cognitive deficits of Alzheimer's disease, including word list learning and delayed recall, naming and praxis. In contrast to Alzheimer's disease, all aspects of cognitive impairment were linearly associated with MMSE scores and there were no qualitatively different patterns of deficits associated with MMSE scores in different ranges of severity. There was no change in performance on any measure across the follow-up period, regardless of the MMSE scores of the patients at baseline. These data suggest that the specific patterns of deficit in chronic schizophrenic patients with severe cognitive deficits differ from Alzheimer's disease in both course and profile of impairment.",
keywords = "Cognitive impairment, Dementia, Institutionalization, Schizophrenia",
author = "Harvey, {Philip D} and Janel Lombardi and Martin Leibman and Leonard White and Michael Parrella and Peter Powchik and Mohs, {Richard C.} and Michael Davidson",
year = "1996",
month = "7",
day = "1",
doi = "10.1002/(SICI)1099-1166(199607)11:7<621::AID-GPS359>3.0.CO;2-V",
language = "English",
volume = "11",
pages = "621--627",
journal = "International Journal of Geriatric Psychiatry",
issn = "0885-6230",
publisher = "John Wiley and Sons Ltd",
number = "7",

}

TY - JOUR

T1 - Performance of chronic schizophrenic patients on cognitive neuropsychological measures sensitive to dementia

AU - Harvey, Philip D

AU - Lombardi, Janel

AU - Leibman, Martin

AU - White, Leonard

AU - Parrella, Michael

AU - Powchik, Peter

AU - Mohs, Richard C.

AU - Davidson, Michael

PY - 1996/7/1

Y1 - 1996/7/1

N2 - Although many chronic schizophrenic patients manifest substantial global cognitive impairment, it is not clear as to whether this impairment should be characterized as dementia. Since many degenerative dementias have a characteristic signature of cognitive impairment and a specific pattern of cognitive decline, examination of schizophrenic patients on these measures can provide information about the qualitative similarity of their cognitive impairment to these other conditions. Three hundred and two chronically hospitalized schizophrenic patients ranging in age from 26 to 98 were examined with the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) neuropsychological battery, as well as a more global measure of cognitive impairment, the Mini-Mental State Examination (MMSE). This assessment was repeated twice, with a 1-year follow-up interval. The CERAD battery measures the prototypical cognitive deficits of Alzheimer's disease, including word list learning and delayed recall, naming and praxis. In contrast to Alzheimer's disease, all aspects of cognitive impairment were linearly associated with MMSE scores and there were no qualitatively different patterns of deficits associated with MMSE scores in different ranges of severity. There was no change in performance on any measure across the follow-up period, regardless of the MMSE scores of the patients at baseline. These data suggest that the specific patterns of deficit in chronic schizophrenic patients with severe cognitive deficits differ from Alzheimer's disease in both course and profile of impairment.

AB - Although many chronic schizophrenic patients manifest substantial global cognitive impairment, it is not clear as to whether this impairment should be characterized as dementia. Since many degenerative dementias have a characteristic signature of cognitive impairment and a specific pattern of cognitive decline, examination of schizophrenic patients on these measures can provide information about the qualitative similarity of their cognitive impairment to these other conditions. Three hundred and two chronically hospitalized schizophrenic patients ranging in age from 26 to 98 were examined with the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) neuropsychological battery, as well as a more global measure of cognitive impairment, the Mini-Mental State Examination (MMSE). This assessment was repeated twice, with a 1-year follow-up interval. The CERAD battery measures the prototypical cognitive deficits of Alzheimer's disease, including word list learning and delayed recall, naming and praxis. In contrast to Alzheimer's disease, all aspects of cognitive impairment were linearly associated with MMSE scores and there were no qualitatively different patterns of deficits associated with MMSE scores in different ranges of severity. There was no change in performance on any measure across the follow-up period, regardless of the MMSE scores of the patients at baseline. These data suggest that the specific patterns of deficit in chronic schizophrenic patients with severe cognitive deficits differ from Alzheimer's disease in both course and profile of impairment.

KW - Cognitive impairment

KW - Dementia

KW - Institutionalization

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=0029998195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029998195&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1099-1166(199607)11:7<621::AID-GPS359>3.0.CO;2-V

DO - 10.1002/(SICI)1099-1166(199607)11:7<621::AID-GPS359>3.0.CO;2-V

M3 - Article

VL - 11

SP - 621

EP - 627

JO - International Journal of Geriatric Psychiatry

JF - International Journal of Geriatric Psychiatry

SN - 0885-6230

IS - 7

ER -